Semaglutide (5 mg, 10 mg)
Price range: $59.99 through $119.95
GLP-1 receptor agonist for glycemic control and metabolic research
 Overview [research use only]
Semaglutide is a synthetic long-acting glucagon-like peptide-1 (GLP-1) receptor agonist designed to mimic the effects of endogenous GLP-1. It enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetite. Preclinical and clinical studies highlight its role in improving glycemic regulation, supporting weight management, and reducing cardiovascular risk factors in models of metabolic disorders. Its extended half-life compared to native GLP-1 makes it a potent compound for metabolic and endocrine research.
Specifications
- Synonyms: Semaglutide, NN9535
- Sequence: Modified GLP-1 analogue with acylated fatty diacid chain
- Molecular formula: C187H291N45O59
- Molecular weight: ~ 4113.6 g/mol
- CAS number: 910463-68-2
- Appearance: White to off-white lyophilized (freeze-dried) powder
 Packaging and Storage
Supplied as a lyophilized powder in vials (5 mg and 10 mg). Store at â20 °C in a dry environment, protected from light. After reconstitution in sterile water or buffer, aliquot and store at 2â8 °C for short-term use or â20 °C for long-term preservation. Avoid repeated freezeâthaw cycles to maintain stability.
Safety and Legal
For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.
| Weight | .5 lbs |
|---|---|
| Dimensions | .63 × .63 × 1.4 in |
| Size |
10 mg ,5 mg |
